Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Gufic Biosciences

Sector: Healthcare | Industry: Drugs & Pharma
R 72.25 -1.40  | -1.90% -32.88% 22.50 559.99
NSE Price: Oct 15, 15:52 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 15, 15:52 72.25 -1.40 -1.90% 74.50 73.65 12,755 71.55 - 74.50
BSE Oct 15, 2019 71.95 -1.45 -1.98% 72.80 73.40 5,254 70.55 - 73.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 64,719 P/B: 6.82 NSE Code: GUFICBIO
52-Week Range: R 51.05 - 109.00 Dividend Yield: 0.07% BSE Code: 509079
TTM EPS: R 3.20 Book Value: R 10.56 Face Value: R 1
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Value Research Stock Advisor now has 38 stock recommendations and new ones are added every month.
Thousands of our members are using the current market conditions to buy great stocks at low prices.

Membership of this premium service is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Gufic Biosciences -23.09 4.88 2.27 -32.22 26.05 32.19 28.16
S&P BSE Small Cap* -13.05 -1.73 -7.18 -9.64 -0.99 3.76 5.39
S&P BSE Healthcare* -11.96 -5.87 -5.15 -15.12 -8.79 -2.02 10.48
Company's return has been calculated on basis of BSE's price.
As on Oct 15, 2019
*As on Oct 14, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 14.79 20.16 23.31
Net Profit 33.17 44.15 38.77
EPS 33.17 43.86 38.59
Book Value 39.18 30.16 23.36
Average
Operating Margin 14.30 12.62 11.54
Net Margin 6.18 5.06 4.30
Return on Networth 33.89 31.74 26.96
Return on Investment 29.65 29.34 26.13
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 0.92 17.27 0.92
Operating Profit -16.73 43.47 -16.73
Net Profit 13.25 84.63 13.25
EPS 13.25 83.50 13.25
TTM
Revenue 3.88 11.87 3.88
Operating Profit 7.95 25.36 7.95
Net Profit 14.34 50.99 14.34
EPS 14.22 50.47 14.22
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Gufic Biosciences 559.99 364.01 24.89 6.74 33.89 6.82 22.50
Astrazeneca Pharma India 5,337.38 771.42 69.56 8.84 20.03 16.67 76.73
Eris Lifesciences 5,801.96 1,005.70 303.64 29.29 28.96 4.70 19.11
Fund Houses invested in the stock
Fund Sep-19 Jun-19 Mar-19 Dec-18 Sep-18
SBI Mutual Fund 4.818 4.818 5.169 6.485 7.166
ICICI Prudential Mutual Fund 2.980 3.025 3.025 1.968 1.095
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: Gufic Biosciences Ltd.

Address: Shop - 37, First Floor, Kamala Bhavan I I, Swami Nityanand Road, Andheri East, Mumbai, Maharashtra - 400069

Email: [email protected]

Website: www.gufic.com

Registrar & Transfer Agent: Link Intime India Pvt Ltd.

Address: C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra, C 101, 247 Park, LBS Marg, Vikhroli (West) | Phone: 91-022-49186000/49186270 | Fax: 91-022-49186060

Email: [email protected]

Website: www.linkintime.co.in

Essential checks
Altman Z-Score
4.07
Piotroski F-Score
7
Modified C-Score
5
5-Years Price to Earnings
22.50
5-Years Price to Book
6.82
Earnings Yield
EBIT / Enterprise value
7.57%
PEG
Price / Earnings to growth ratio
0.57
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,134.25 -1.66%
Caplin Point Laboratories R398.40 -0.91%
Eris Lifesciences R424.80 -1.72%
FDC R159.35 -0.50%
JB Chemicals & Pharma R356.05 -0.96%
Laurus Labs R319.55 -0.11%
Strides Pharma Science R355.60 +5.05%
Sun Pharma Adv. Research R119.90 +0.88%
Suven Life Sciences R265.70 +2.90%
Wockhardt R253.55 -0.06%
As on Oct 15, 15:59